Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy

Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate that pharmacological activation of the soluble guanylate cyclase (sGC) – cyclic guanosine monophosphate (cGMP) pathway may also exert reverse-remodeling properties in the...

Full description

Bibliographic Details
Main Authors: Mihály Ruppert, Sevil Korkmaz-Icöz, Shiliang Li, Paige Brlecic, Balázs Tamás Németh, Attila Oláh, Eszter M. Horváth, Gábor Veres, Sven Pleger, Niels Grabe, Béla Merkely, Matthias Karck, Tamás Radovits, Gábor Szabó
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2018.01869/full
id doaj-cf189accbc1641079b76ccfe12690df7
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Mihály Ruppert
Mihály Ruppert
Sevil Korkmaz-Icöz
Shiliang Li
Paige Brlecic
Balázs Tamás Németh
Attila Oláh
Eszter M. Horváth
Gábor Veres
Sven Pleger
Niels Grabe
Niels Grabe
Béla Merkely
Matthias Karck
Tamás Radovits
Gábor Szabó
spellingShingle Mihály Ruppert
Mihály Ruppert
Sevil Korkmaz-Icöz
Shiliang Li
Paige Brlecic
Balázs Tamás Németh
Attila Oláh
Eszter M. Horváth
Gábor Veres
Sven Pleger
Niels Grabe
Niels Grabe
Béla Merkely
Matthias Karck
Tamás Radovits
Gábor Szabó
Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
Frontiers in Physiology
left ventricular hypertrophy
pressure unloading
reverse remodeling
cinaciguat
cGMP
author_facet Mihály Ruppert
Mihály Ruppert
Sevil Korkmaz-Icöz
Shiliang Li
Paige Brlecic
Balázs Tamás Németh
Attila Oláh
Eszter M. Horváth
Gábor Veres
Sven Pleger
Niels Grabe
Niels Grabe
Béla Merkely
Matthias Karck
Tamás Radovits
Gábor Szabó
author_sort Mihály Ruppert
title Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title_short Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title_full Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title_fullStr Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title_full_unstemmed Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title_sort comparison of the reverse-remodeling effect of pharmacological soluble guanylate cyclase activation with pressure unloading in pathological myocardial left ventricular hypertrophy
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2019-01-01
description Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate that pharmacological activation of the soluble guanylate cyclase (sGC) – cyclic guanosine monophosphate (cGMP) pathway may also exert reverse-remodeling properties in the myocardium. Therefore, we aimed to investigate the effects of the sGC activator cinaciguat in a rat model of LVH and compare it to the “gold standard” pressure unloading therapy.Methods: Abdominal aortic banding was performed for 6 or 12 weeks. Sham operated animals served as controls. Pressure unloading was induced by removing the aortic constriction after week 6. The animals were treated from week 7 to 12, with 10 mg/kg/day cinaciguat or with placebo p.o., respectively. Cardiac function and morphology were assessed by left ventricular pressure-volume analysis and echocardiography. Additionally, key markers of myocardial hypertrophy, fibrosis, nitro-oxidative stress, apoptosis and cGMP signaling were analyzed.Results: Pressure unloading effectively reversed LVH, decreased collagen accumulation and provided protection against oxidative stress and apoptosis. Regression of LVH was also associated with a full recovery of cardiac function. In contrast, chronic activation of the sGC enzyme by cinaciguat at sustained pressure overload only slightly influenced pre-established hypertrophy. However, it led to increased PKG activity and had a significant impact on interstitial fibrosis, nitro-oxidative stress and apoptosis. Amelioration of the pathological structural alterations prevented the deterioration of LV systolic function (contractility and ejection fraction) and improved myocardial stiffness.Conclusion: Our results indicate that both cinaciguat treatment and pressure unloading evoked anti-remodeling effects and improved LV function, however in a differing manners.
topic left ventricular hypertrophy
pressure unloading
reverse remodeling
cinaciguat
cGMP
url https://www.frontiersin.org/article/10.3389/fphys.2018.01869/full
work_keys_str_mv AT mihalyruppert comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT mihalyruppert comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT sevilkorkmazicoz comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT shiliangli comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT paigebrlecic comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT balazstamasnemeth comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT attilaolah comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT esztermhorvath comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT gaborveres comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT svenpleger comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT nielsgrabe comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT nielsgrabe comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT belamerkely comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT matthiaskarck comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT tamasradovits comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT gaborszabo comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
_version_ 1725265464481808384
spelling doaj-cf189accbc1641079b76ccfe12690df72020-11-25T00:46:27ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2019-01-01910.3389/fphys.2018.01869422864Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular HypertrophyMihály Ruppert0Mihály Ruppert1Sevil Korkmaz-Icöz2Shiliang Li3Paige Brlecic4Balázs Tamás Németh5Attila Oláh6Eszter M. Horváth7Gábor Veres8Sven Pleger9Niels Grabe10Niels Grabe11Béla Merkely12Matthias Karck13Tamás Radovits14Gábor Szabó15Experimental Research Laboratory, Heart and Vascular Center, Semmelweis University, Budapest, HungaryLaboratory of Experimental Cardiac Surgery, Department of Cardiac Surgery, Heidelberg University, Heidelberg, GermanyLaboratory of Experimental Cardiac Surgery, Department of Cardiac Surgery, Heidelberg University, Heidelberg, GermanyLaboratory of Experimental Cardiac Surgery, Department of Cardiac Surgery, Heidelberg University, Heidelberg, GermanyLaboratory of Experimental Cardiac Surgery, Department of Cardiac Surgery, Heidelberg University, Heidelberg, GermanyExperimental Research Laboratory, Heart and Vascular Center, Semmelweis University, Budapest, HungaryExperimental Research Laboratory, Heart and Vascular Center, Semmelweis University, Budapest, HungaryLaboratory of Oxidative Stress, Department of Physiology, Institute of Clinical Experimental Research, Semmelweis University, Budapest, HungaryLaboratory of Experimental Cardiac Surgery, Department of Cardiac Surgery, Heidelberg University, Heidelberg, GermanyLaboratory for Molecular and Translational Cardiology, Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, Heidelberg, GermanyResearch Group on Epidermal Systems Biology, Hamamatsu Tissue Imaging and Analysis Center, Bioquant, Heidelberg University, Heidelberg, GermanyNational Center for Tumor Diseases, Medical Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, GermanyExperimental Research Laboratory, Heart and Vascular Center, Semmelweis University, Budapest, HungaryLaboratory of Experimental Cardiac Surgery, Department of Cardiac Surgery, Heidelberg University, Heidelberg, GermanyExperimental Research Laboratory, Heart and Vascular Center, Semmelweis University, Budapest, HungaryLaboratory of Experimental Cardiac Surgery, Department of Cardiac Surgery, Heidelberg University, Heidelberg, GermanyBackground: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate that pharmacological activation of the soluble guanylate cyclase (sGC) – cyclic guanosine monophosphate (cGMP) pathway may also exert reverse-remodeling properties in the myocardium. Therefore, we aimed to investigate the effects of the sGC activator cinaciguat in a rat model of LVH and compare it to the “gold standard” pressure unloading therapy.Methods: Abdominal aortic banding was performed for 6 or 12 weeks. Sham operated animals served as controls. Pressure unloading was induced by removing the aortic constriction after week 6. The animals were treated from week 7 to 12, with 10 mg/kg/day cinaciguat or with placebo p.o., respectively. Cardiac function and morphology were assessed by left ventricular pressure-volume analysis and echocardiography. Additionally, key markers of myocardial hypertrophy, fibrosis, nitro-oxidative stress, apoptosis and cGMP signaling were analyzed.Results: Pressure unloading effectively reversed LVH, decreased collagen accumulation and provided protection against oxidative stress and apoptosis. Regression of LVH was also associated with a full recovery of cardiac function. In contrast, chronic activation of the sGC enzyme by cinaciguat at sustained pressure overload only slightly influenced pre-established hypertrophy. However, it led to increased PKG activity and had a significant impact on interstitial fibrosis, nitro-oxidative stress and apoptosis. Amelioration of the pathological structural alterations prevented the deterioration of LV systolic function (contractility and ejection fraction) and improved myocardial stiffness.Conclusion: Our results indicate that both cinaciguat treatment and pressure unloading evoked anti-remodeling effects and improved LV function, however in a differing manners.https://www.frontiersin.org/article/10.3389/fphys.2018.01869/fullleft ventricular hypertrophypressure unloadingreverse remodelingcinaciguatcGMP